Cite
HARVARD Citation
Polidori, D. et al. (2016). Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy. Diabetes, obesity & metabolism. 18 (4), pp. 348-354. [Online].